United Therapeutics Stock
Price
Target price
€301.80
€301.80
0.860%
2.6
0.860%
€290.08
18.07.24 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
United Therapeutics gained 0.860% compared to yesterday.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
However, we have a potential of -3.91% for United Therapeutics as the target price of 290 € is below the current price of 301.8 €.
Pros and Cons of United Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 0.860% | 2.374% | 2.097% | 35.276% | 52.232% | 94.710% | 343.824% |
| Ironwood Pharmaceuticals | -3.250% | 0.000% | 6.250% | -37.696% | -41.667% | -46.396% | - |
| Arrowhead Pharmaceuticals Inc. | 0.550% | 0.892% | 9.053% | -19.766% | -7.599% | -54.889% | -2.910% |
| Novocure Ltd | -1.560% | 2.547% | -5.266% | -51.644% | 18.459% | -89.484% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $300.00 to $370.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for UTHR provided by MarketBeat